Document ID: chunk:federal_register_of_legislation:F2019L00633:reg:9
Version: federal_register_of_legislation:F2019L00633
Segment Type: reg
Provision Reference: reg 9
Character Range: 3267–5726

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting rapidly progressive crescentic glomerulonephritis or death from rapidly progressive crescentic glomerulonephritis with the circumstances of a person's relevant service:
(1)          having an infection from the specified list of infections within the two months before the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: specified list of infections is defined in the Schedule 1 - Dictionary.
(2)          having an autoimmune disorder from the specified list of autoimmune disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: specified list of autoimmune disorders is defined in the Schedule 1 - Dictionary.
(3)          having infiltration of the kidneys due to a disorder from the specified list of infiltrative disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: specified list of infiltrative disorders is defined in the Schedule 1 - Dictionary.
(4)          having a renal disorder from the specified list of renal disorders at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: specified list of renal disorders is defined in the Schedule 1 - Dictionary.
(5)          having a malignant neoplasm at the time of the clinical onset of rapidly progressive crescentic glomerulonephritis;
(6)          taking a drug or a drug from a class of drugs from the specified list of drugs within the seven days before the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: specified list of drugs is defined in the Schedule 1 - Dictionary.
(7)          having at least three episodes of acute volatile substance intoxication within the 30 days before the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: acute volatile substance intoxication is defined in the Schedule 1 - Dictionary.
(8)          inhaling or absorbing an organic solvent for at least one hour per week for at least the three months before the clinical onset of rapidly progressive crescentic glomerulonephritis;
Note: organic solvent is defined in the Schedule 1 - Dictionary.
(9)          inability to obtain appropriate clinical management for rapidly progressive crescentic glomerulonephritis.